Shandong Cynda ChemicalLtd Zukünftiges Wachstum
Future Kriterienprüfungen 4/6
Shandong Cynda ChemicalLtd is forecast to grow earnings and revenue by 109% and 14.1% per annum respectively. EPS is expected to grow by 108.9% per annum. Return on equity is forecast to be 9.6% in 3 years.
Wichtige Informationen
109.0%
Wachstumsrate der Gewinne
108.9%
EPS-Wachstumsrate
Chemicals Gewinnwachstum | 38.3% |
Wachstumsrate der Einnahmen | 14.1% |
Zukünftige Eigenkapitalrendite | 9.6% |
Analystenabdeckung | Low |
Zuletzt aktualisiert | 24 Jun 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
Keine Aktualisierungen
Gewinn- und Umsatzwachstumsprognosen
Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
---|---|---|---|---|---|
12/31/2026 | 3,194 | 256 | N/A | 299 | 1 |
12/31/2025 | 2,878 | 146 | N/A | 70 | 1 |
12/31/2024 | 2,489 | 27 | N/A | 47 | 1 |
9/30/2024 | 2,311 | -102 | -103 | 29 | N/A |
6/30/2024 | 2,450 | -144 | -273 | -112 | N/A |
3/31/2024 | 2,425 | -156 | -50 | 112 | N/A |
12/31/2023 | 2,482 | -98 | -193 | -1 | N/A |
9/30/2023 | 2,720 | 67 | -368 | -91 | N/A |
6/30/2023 | 2,767 | 235 | -92 | 216 | N/A |
3/31/2023 | 3,113 | 350 | -90 | 210 | N/A |
12/31/2022 | 3,126 | 381 | 67 | 364 | N/A |
9/30/2022 | 3,162 | 418 | 346 | 607 | N/A |
6/30/2022 | 2,829 | 316 | 269 | 526 | N/A |
3/31/2022 | 2,318 | 232 | 140 | 368 | N/A |
12/31/2021 | 2,203 | 177 | 26 | 224 | N/A |
9/30/2021 | 2,075 | 137 | 26 | 174 | N/A |
6/30/2021 | 1,968 | 139 | 149 | 260 | N/A |
3/31/2021 | 1,974 | 172 | 221 | 337 | N/A |
12/31/2020 | 1,896 | 176 | 232 | 361 | N/A |
9/30/2020 | 1,754 | 176 | 255 | 410 | N/A |
6/30/2020 | 1,682 | 173 | 134 | 343 | N/A |
3/31/2020 | 1,582 | 189 | 172 | 481 | N/A |
12/31/2019 | 1,575 | 205 | 64 | 400 | N/A |
9/30/2019 | 1,641 | 222 | -119 | 251 | N/A |
6/30/2019 | 1,658 | 255 | -173 | 190 | N/A |
3/31/2019 | 1,684 | 263 | -179 | 87 | N/A |
12/31/2018 | 1,636 | 251 | -170 | 157 | N/A |
9/30/2018 | 1,412 | 211 | -65 | 184 | N/A |
6/30/2018 | 1,344 | 179 | N/A | 131 | N/A |
3/31/2018 | 1,149 | 114 | N/A | 117 | N/A |
1/1/2018 | 1,119 | 110 | N/A | 73 | N/A |
9/30/2017 | 1,064 | 102 | N/A | 74 | N/A |
6/30/2017 | 957 | 100 | N/A | 70 | N/A |
3/31/2017 | 945 | 102 | N/A | -13 | N/A |
12/31/2016 | 866 | 98 | N/A | 80 | N/A |
12/31/2015 | 804 | 99 | N/A | 13 | N/A |
12/31/2014 | 823 | 119 | N/A | 139 | N/A |
12/31/2013 | 691 | 70 | N/A | 60 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: 603086 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.9%).
Ertrag vs. Markt: 603086 is forecast to become profitable over the next 3 years, which is considered above average market growth.
Hohe Wachstumserträge: 603086 is expected to become profitable in the next 3 years.
Einnahmen vs. Markt: 603086's revenue (14.1% per year) is forecast to grow faster than the CN market (14% per year).
Hohe Wachstumseinnahmen: 603086's revenue (14.1% per year) is forecast to grow slower than 20% per year.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: 603086's Return on Equity is forecast to be low in 3 years time (9.6%).